drugset / Trial / NCT01247883

A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers

NCT01247883

Phase 1 Completed 13 enrolled Pfizer Incyte Corporation · collab
RandomizedCrossoverOpen-labelBasic science

Summary

This study investigates the safety, tolerability and pharmacokinetics of PF-04634817 when respectively given orally as a single tablet dose and a single dose of a solution.

Timeline

Start
2010-10
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator PF-04634817 Small molecule 20 mg Oral

Indications

No indication recorded.